You are here
- Home
- Drug Products
All Drug Products
- collapse An Open-label, Phase I Study to Assess the Pharmacokinetics of R406 in Subjects With Renal Impairment Compared to Healthy Subjects Following Administration of a Single Dose of Fostamatinib 150 mg
-
expand
A Phase I, Open-label, Single-Centre Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration to Healthy Male Subjects
- Study Id
- D6702C00030
- Disease
- depressive disorder
- Drug Name
- AZD6765
- Study Name
- D6702C00030
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
- collapse An Epidemiological, Observational Study to Describe Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease (GERD)
- collapse A retrospective, medical record study to investigate the current situation of biopsy testing in the Swedish inoperable Non Small Cell Lung Cancer patient population.
- collapse An NIS Registry for the Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic NSCLC (Stage IIIB/IV Non-small Cell Lung Cancer)
- collapse Iressa Follow-up Trial
- collapse A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
- collapse National Survey on GERD Patients (Adults and Children)
- collapse A Phase I, Double-blind, Randomized, Placebo-controlled', Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD5213 After Administration of Multiple Ascending Doses for 10 Days in Healthy Male and Non-fertile Female Volunteers
- collapse Comparing Efficacy between Anti-microtubule and Non-anti-microtubule as 3th Therapy after 2nd line EGFR-TKI therapy
